期刊文献+

比格犬血浆中托烷司琼的HPLC法测定 被引量:6

Determination of Tropisetron in Beagle Dogs' Plasma by HPLC
下载PDF
导出
摘要 建立了比格犬血浆样品中托烷司琼的反相高效液相色谱检测法。血浆样品 ,加入盐酸三环哌酯作内标 ,用乙酸乙酯提取 ,经稀盐酸反洗 ,再用二氯甲烷提取。色谱条件 :C8柱 ;流动相 :甲醇 -水 (5 5∶4 5 ) ,加 0 3%三乙胺 ,用冰醋酸调pH 7 2 ;检测波长 2 83nm。线性范围 5 4 5~70 0ng/mL ,最低检测浓度为 3 0ng/mL ,回收率为 79 9%~ 85 8% ,日内RSD为 1 0 6 %~4 2 7% ,日间RSD为 2 94 %~ 9 89%。采用本法对比格犬口服托烷司琼的药代动力学进行了研究。 A reversed-phase high performance liquid chromatographic method is described for the determination of tropisetron in plasma of beagle dogs.Tropisetron in plasma was extracted with ethyl acetate after the addition of the internal standard tricyclopinate hydrochloride.The organic phase was re-extracted with dilute hydrochloric acid and the aqueous phase was back-extracted with dichloromethane.After the extract was evaporated to dryness,the residue was dissolved in methanol and then separated on a C 8 column.The mobile phase consisted of methanol-water(55∶45)with 0 3 % triethylamine and was adjusted to pH 7 2 by acetic acid.The detector was set at UV 283 nm.The linear range of the calibration curve was 5 45~700 ng/mL and the minimal detectable concentration was 3 0 ng/mL.The recovery of the method was 79 9 %~85 8 %.The within-day and between-day precisions were 1 06 %~4 27 % and 2 94 %~9 89 %,respectively.The method has been applied to the pharmacokinetic study of tropisetron in beagle dogs after po 20 mg.fbeagledogs .Tropisetronin
出处 《药物分析杂志》 CAS CSCD 北大核心 1998年第6期369-372,共4页 Chinese Journal of Pharmaceutical Analysis
关键词 托烷司琼 高效液相色谱 药代动力学 血药浓度 tropisetron,HPLC,pharmacokinetics
  • 相关文献

同被引文献22

  • 1谭明,吴国平,李雪宁,徐红蓉.国产与进口托烷司琼胶囊的人体生物等效性[J].中国临床药学杂志,2004,13(4):208-211. 被引量:2
  • 2付良青,黄丰,唐欣,钱平利,刘泽源.进口盐酸托烷司琼胶囊在中国人体的药代动力学[J].中国药理学通报,2004,20(9):1067-1069. 被引量:4
  • 3Haus U, Varga B, Stratz T, et al. Oral treatment of fibromyalgia with tropisetron given over 28 days: influence on functional and vegetative symptoms,psychometric parameters and pain[ J]. Scand J Rheumatol,2000,29(Suppl) :55.
  • 4Bruijn KM. Tropisetron: a review of the clinical experience[J]. Drug,1992,43(Supp13): 11.
  • 5Fischer V, Baldeck JP, Tse FLS. Pharmacokinetics and metabolism of the 5-hydroxytryptamine antagonist tropisetron after single oral doses in humans[J]. Drug Metab and Dispos,1992,20(4) :603.
  • 6Kim MK, Cho JY, Lim HS, et al. Effect of the CYP2D6 genotype on the pharmacokinetics of tropisetron in healthy Korean subjects[J]. Eur J Clin Pharmacol , 2003 , 59(2):111.
  • 7Bruijn KM. Tropisetron: A review of the clinical experience [ J ].Drug, 1992 ;43 ( Suppl. 3 ): S11 - S22.
  • 8Haus U, Varga B, Stratz T, et al. Oral treatment of fibromyalgia with tropisetron given over 28 days: influence on functional and vegetative symptoms, psychometric parameters and pain [ J ]. Scand J Rheumatol,2000;29(Suppl. ) : S55 -S58.
  • 9Fischer V, Baldeck JP, Tse FLS. Phannacokinetics and metabolism of the 5 - hydroxytryptamine antagonist tropisetron after single oral doses in humans[ J ]. Drug Metab Dispos, 1992 ;20:603 - 607.
  • 10Steffen Bauer, Elke Stormer, Rolf Kaiser, et al. Simultaneous determination of ondansetron and tropisetron in human plasma using HPLC with UV detection. Biomed Chromatogr ,2002 ,16 : 187

引证文献6

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部